Concepedia

Amy Rappaport

AR

Statistics

Publications

17

Citations

4.3K

H-Index

16

Active since

2007

Affiliations

Howard Hughes Medical Institute(Current)

Memorial Sloan Kettering Cancer Center

Cold Spring Harbor Laboratory

University of California, San Francisco

Research Institute of Molecular Pathology

Amy Rappaport is an author at Howard Hughes Medical Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2007–2024

17

Publications

17

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

Stefan Glaser, Erinna F. Lee, Evelyn Trounson et al. · Genes & Development · 2012 · 418 citations · Full text

Medicine, Oncology, Pharmacology +17

MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia

Chong Chen, Yu Liu, Amy Rappaport et al. · Cancer Cell · 2014 · 322 citations · Full text

Medicine, Cancer Biology, Oncology +12

An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance

Johannes Zuber, Amy Rappaport, Weijun Luo et al. · Genes & Development · 2011 · 280 citations · Full text

Medicine, Genetics, Oncology +17

Mouse models of human AML accurately predict chemotherapy response

Johannes Zuber, Ina Radtke, Timothy S. Pardee et al. · Genes & Development · 2009 · 279 citations · Full text

Medicine, Cancer Biology, Oncology +13

1–5 of 17